Detalles de la búsqueda
1.
Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.
Vaccine
; 37(35): 4947-4955, 2019 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307876
2.
Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study.
Front Immunol
; 8: 625, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620382
3.
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.
Front Immunol
; 6: 243, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26042126
4.
CD207⺠cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice.
Vaccine
; 32(11): 1229-32, 2014 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24486365
5.
Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors.
Vaccine
; 31(2): 354-61, 2013 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23146677
6.
Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue.
Vaccine
; 28(51): 8162-8, 2010 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-20937314
Resultados
1 -
6
de 6
1
Próxima >
>>